Aemia Treatment Market

Anemia Treatment Market: Increased Preference for Combination Therapy Including Erythrocyte Stimulating Agents and Iron Supplements to Offer Substantial Revenue Opportunity: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2028

2019-02-18
REP-GB-8966
58 Tables
134 Figures
257 pages

Home
Market Research Reports
Healthcare, Pharmaceuticals and Medical devices
Aemia Treatment Market

An Incisive, In-depth Analysis on the Aemia Treatment Market

This study offers a comprehensive, 360 degree analysis on the Aemia Treatment market, bringing to fore insights that can help stakeholders identify the opportunities as well as challenges. It tracks the global Aemia Treatment market across key regions, and offers in-depth commentary and accurate quantitative insights. The study also includes incisive competitive landscape analysis, and provides key recommendations to market players on winning imperatives and successful strategies.

Request a sample

Ask An Analyst

Request Special Price

Request Methodology

Anemia Treatment Market to Witness Healthy Competition Due to Increasing Product Consolidation Among Major Manufacturers

Over the years, the rise in consolidation activities, including drug development and new launches, mergers, agreements, collaborations, investments in research and development activities, and drug patent transfers among global leaders and regional players have been trademark for the overall competition in the global anemia treatment market. Many global players are also setting up their manufacturing hubs and distribution channels in emerging countries such as China, India, and Brazil in order to increase their product potential and footprint in developing and poor economies. With continuous product launches and the aforesaid consolidated factors, the growth of the anemia treatment market is anticipated to surge during the forecast period.

Extensive Investments in R&D Activities by Key Drug Manufacturers to Bring Noble and Effective Medicaments into the Anemia Treatment Market

Key manufacturers in the anemia treatment market are constantly investing in research and development activities to design, develop, and introduce therapeutically-effective medicaments such as dietary supplements, erythrocyte simulating agents, antibiotics, chelating agents, and other biological products. Additionally, they are also upgrading their existing consumable product portfolios, ranging from dietary supplements to biological, so as to have a competitive edge in the market. These companies are also trying to introduce new drugs for anemia treatment that will play a significant role in improving and providing quality healthcare in developing and poor economies. Drug manufacturers operating in the field of anemia treatment have also recorded strong financial growth over the last few years. For instance, Amgen’s Epoetin alpha used for the treatment of anemia chronic kidney disease has recorded significant growth since its market launch. The company predicts that, the product revenue will further increase during the forecast period. Thus, an increase in the number of both, biologics and generic drugs by key manufacturers, and increasing research and development will contribute significantly towards the growth of the anemia treatment market during the forecast period.

Potential for Biosimilars for Anemia Treatment

Anemia of Chronic Kidney Disease (CKD) is the major disease in the anemia treatment market, and therefore, medicaments used for its treatment are the major revenue generating products in the market. It is considered that, the use of biologics such as erythropoietin stimulating agents (ESAs) will play a significant role in the anemia treatment market, globally. The emergence of ESAs and rising demand for other biosimilar medications will bring new avenues of opportunities for drug manufacturers operating in the anemia treatment market. Biosimilar drugs have also become one of the cost-effective methods for anemia treatment. Besides, these products are readily available, globally, with highest patient access. Over the years, there has been increase in FDA approval for various biosimilars for anemia treatment, and this has led to providing tremendous benefits to patients suffering from anemia of chronic kidney disease. For example, in 2018, the FDA approved Pfizer’s biosimilar - Epoetin Alfa (Retacrit), fostering a sustainable marketplace for biosimilars to treat anemia.

Major Agreements and Partnerships Among Key Drug Manufacturers for Anemia Treatment

With new developments and research activities in pharmaceutical industries, and biomedical research, medication efficacy to treat anemia and other diseases is also increasing, globally. To strengthen their product portfolio and develop noble drugs for anemia treatment, various drug manufacturers are building new business models to increase product revenue and prevent market loss. Besides, new partnership-based models within drug manufacturers will help in adding new dimensions, and also reshape the research and development programs aimed at anemia treatment. In the last few years, activities such as mergers and partnerships within the pharmaceutical industry have continued to evolve, and have paved the way for drug development for anemia treatment. Additionally, open collaborations and new product-based business models such as partnerships between drug manufacturers and regional distributors are expected to drive the anemia treatment market during the forecast period, leading to substantial regional growth. For more information, get in touch with our expert analyst.

Anemia Treatment Market: Competitive Landscape

This section of the anemia treatment market report features the profiles of key players operating in the anemia treatment market based on their differential strategies, anemia treatment product offerings, marketing approach, and company dashboard. Examples of some of the key players featured in this report include Amgen Inc., Hoffmann-La Roche Ltd, Pfizer Inc., Novartis AG, Janssen Pharmaceuticals, Inc. Teva Pharmaceutical Industries Ltd, AMAG Pharmaceuticals, Rockwell Medical, and Akebia Therapeutics, among others.

Key drug manufacturers in the anemia treatment market are focusing on marketing strategies to increase both, their product portfolio as well as geographical presence. Most of the companies operating in anemia medications are focused on aggressive pricing strategies in order to lead the market for anemia treatment. Some other key market strategies followed by anemia treatment pharmaceutical companies include research and development agreements to increase product development, partnering with local as well as global retailers, and long-term partnerships with distribution sales such as institutional pharmacies, retail pharmacies, and mail-order pharmacies.

Anemia Treatment Market: Additional Questions Answered

Some of the additional questions addressed in this report on the anemia treatment market”

What is the revenue potential of the anemia treatment markets across North America and Europe?
Who are the key competitors and what are their portfolios in the anemia treatment market?
What are the major challenges influencing the growth of the anemia treatment market?
How is intervention from regulatory authorities shaping the growth of the anemia treatment market?

Research Methodology

The anemia treatment market has been estimated based on an epidemiology-based approach. The market was studied by estimating the base year market side in different region/countries. The market was estimated based on product dosage for treatment in the top 20 countries, globally. Other qualitative factors analyzed during market value estimation include awareness level of usage of anemia treatment medications including product usage, region, and prevalence of anemia. This information was further validated with rigorous primary research (including interviews, surveys, in-person interactions, and viewpoints of seasoned analysts) and secondary research (including verified paid sources, authentic trade journals, and resourceful databases). The research study on the anemia treatment market also includes top trends and macro- as well as micro-economic factors shaping the anemia treatment market. With this approach, the report on the anemia treatment market anticipates the industry attractiveness of every major segment in the anemia treatment market over the forecast period.

A recent market study published by FMI, titled 'Anemia Treatment Market: Global Industry Analysis 2013–2017 and Opportunity Assessment 2018–2028', consists of a comprehensive assessment of the most important market dynamics. On conducting a thorough research on the historic as well as current growth parameters of the anemia treatment market, growth prospects of the market are obtained with maximum precision. The report features unique and salient factors that may have a huge impact on the development of the anemia treatment market during the forecast period. It can help players modify their manufacturing and marketing strategies to envisage maximum growth in the anemia treatment market in the coming years. The report provides detailed information about the current and future growth prospects of the anemia treatment market in the most comprehensive way for the better understanding of readers.

Chapter 1 – Executive Summary

The report commences with the executive summary of the anemia treatment market, which includes the summary of key findings and key statistics of the market. It also includes market value (US$ million) estimates of the leading segments of the anemia treatment market.

Chapter 2 – Market Introduction

Readers can find detailed taxonomy and definition of the anemia treatment market in this chapter, which will help them understand the basic information about the anemia treatment market.

Chapter 3 – Market Opportunity Analysis

This chapter explains the key macro-economic factors that are expected to influence the growth of the anemia treatment market over the forecast period. Along with macroeconomic factors, this section also highlights the opportunity analysis for the anemia treatment market. It helps readers understand the market opportunities, based on which they can plan their strategies.

Chapter 4 – Market Background

This chapter highlights the key dynamics of the anemia treatment market, which includes the drivers, restraints, and trends. The supply-side drivers as well as demand-side drivers of the anemia treatment market are explained in this chapter. This chapter is expected to enable readers to understand the factors that are propelling the growth of the anemia treatment market, as well as those that are likely to hamper the growth of the anemia treatment market. Moreover, readers will understand the key trends followed by leading manufacturers in the anemia treatment market.

Chapter 5 – Global Economic Outlook

This section highlights the healthcare spending of the top countries in each region. It also explains the global and regional healthcare market outlook. Regional healthcare markets are analyzed in depth to assess the political, economic, and business environment outlook of respective regions.

Chapter 6 – Key Inclusions

This chapter highlights the key inclusions of the anemia treatment market report, which includes regional pricing analysis, epidemiology-based scenario by region, regulatory guidelines, and list of manufacturers.

Chapter 7 – North America Anemia Treatment Market Analysis 2013–2017 and Opportunity Assessment 2018–2028

This chapter includes detailed analysis of the growth of the North America anemia treatment market, along with country-wise assessment that includes the U.S. and Canada. Readers can also find regional trends, regulations, and market growth based on treatment, disease, route of administration, distribution channel, and country in the North American market.

Chapter 8 – Latin America Anemia Treatment Market Analysis 2013–2017 and Opportunity Assessment 2018–2028

Readers can find detailed information about factors such as incremental opportunity, Y-O-Y growth, and regional trends that are impacting the growth of the Latin America anemia treatment market. This chapter also includes the growth prospects of the anemia treatment market in leading LATAM countries/regions such as Brazil, Mexico, and the Rest of Latin America.

Chapter 9 – Europe Anemia Treatment Market Analysis 2013–2017 and Opportunity Assessment 2018–2028

Important growth prospects of the anemia treatment market based in several European countries/regions, such as EU4, Spain, Russia, and the Rest of Europe are included in this chapter.

Chapter 10 – East Asia Anemia Treatment Market Analysis 2013–2017 and Opportunity Assessment 2018–2028

Detailed information about factors such as incremental opportunity, Y-O-Y growth, and regional trends that are impacting the growth of the East Asia anemia treatment market are included in this chapter. It also includes the growth prospects of the anemia treatment market in leading East Asian countries such as China, Japan, and South Korea.

Chapter 11 – South Asia Anemia Treatment Market Analysis 2013–2017 and Opportunity Assessment 2018–2028

India, Indonesia, Malaysia, Thailand, and the Rest of South Asia are the leading countries/regions in South Asia that are the prime subjects of assessment to obtain the growth prospects of the South Asia anemia treatment market, in this chapter. Readers can find thorough information about the growth parameters of the South Asia anemia treatment market during the period 2018-2028.

Chapter 12 – Oceania Anemia Treatment Market Analysis 2013–2017 and Opportunity Assessment 2018–2028

This chapter consists of important parameters that have a huge impact on the growth of the anemia treatment market in Oceania, based on market segmentation, during the forecast period. This chapter also provides an overview of the drivers, restraints, and trends in the Oceania anemia treatment market.

Chapter 13 – MEA Anemia Treatment Market Analysis 2013–2017 and Opportunity Assessment 2018–2028

Important growth prospects of the anemia treatment market based in several MEA countries/regions such as GCC Countries, South Africa, and the Rest of MEA are included in this chapter.

Chapter 14 – Emerging Nations Anemia Treatment Market Analysis 2013–2017 and Opportunity Assessment 2018–2028

Important growth prospects of the anemia treatment market in emerging nations such as China, India, and Brazil are included in this chapter.

Chapter 15 – Forecast Factors: Relevance and Impact

This chapter highlights the key factors that are taken into consideration while forecasting the market value of the global anemia treatment market. The impact of these forecast factors in different regions is also mentioned in this chapter.

Chapter 16 – Forecast Assumptions

This section provides the relevant factors and their impact on the market that were taken into consideration to build the market for the current year 2017 and make the market forecast (2018–2028). It will help readers gain more information and know which factors play a key role in shaping the present and future of the market.

Chapter 17 – Competition Analysis

In this chapter, readers can find a comprehensive list of all the leading stakeholders in the anemia treatment market, along with detailed information about each company, including company overview, revenue shares, strategic overview, and recent company developments. Players featured in the report include Amgen Inc., Hoffmann-La Roche Ltd, Pfizer Inc., Novartis AG, Janssen Pharmaceuticals, Inc. Teva Pharmaceutical Industries Ltd, AMAG Pharmaceuticals, Rockwell Medical, and Akebia Therapeutics, among others.

Chapter 18 – Global Anemia Treatment Market Analysis 2013–2017 & Opportunity Assessment 2018–2028 by Region

This chapter explains how the anemia treatment market will grow across various geographic regions such as North America, Latin America, Europe, East Asia, South Asia, Oceania, the Middle East & Africa (MEA), and Emerging Nations.

Chapter 19 – Global Anemia Treatment Market Analysis 2013–2017 & Opportunity Assessment 2018–2028 by Treatment

Based on treatment, the anemia treatment market is segmented into medications and dietary supplements. In this chapter, readers can find detailed analysis of the anemia treatment market by different treatment types, and their expected growth over the forecast period.

Chapter 20 – Global Anemia Treatment Market Analysis 2013–2017 & Opportunity Assessment 2018–2028 by Disease

Based on disease, the anemia treatment market is segmented into normocytic anemia, microcytic anemia, and macrocytic anemia. This section helps readers understand the penetration of the anemia treatment market based on these diseases, over the forecast period.

Chapter 21 – Global Anemia Treatment Market Analysis 2013–2017 & Opportunity Assessment 2018–2028 by Route of Administration

Based on route of administration, the global anemia treatment market can be classified into injectable route and oral route. In this chapter, readers can understand the market attractive analysis based route of administration.

Chapter 22 – Global Anemia Treatment Market Analysis 2013–2017 & Opportunity Assessment 2018–2028 by Distribution Channel

Based on distribution channel, the global anemia treatment can be classified into institutional pharmacies, retail pharmacies, and mail-order pharmacies. In this chapter, readers can understand the market attractive analysis based on distribution channel.

Chapter 23 – Global Anemia Treatment Market Analysis 2013–2017 and Opportunity Assessment 2018–2028

This section explain the global market analysis and forecast of the anemia treatment market. It also highlights the incremental opportunity for the anemia treatment market, along with absolute dollar opportunity for every year during the forecast period of 2018-2028.

Chapter 24 – Assumptions and Acronyms

This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the report.

Chapter 25 – Research Methodology

This chapter helps readers understand the research methodology that has been followed to obtain various conclusions, important qualitative information, and quantitative information about the anemia treatment market.